The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study

被引:0
|
作者
Sara Olofsson
Katarina Gralén
Christina Hoxer
Paul Okhuoya
Ulf Persson
机构
[1] The Swedish Institute for Health Economics,
[2] IHE,undefined
[3] BioMarin Pharmaceutical Inc,undefined
关键词
Phenylketonuria; Phenylalanine hydroxylase deficiency; Quality of life; Burden of illness; Time trade-off; Discrete choice; I1 Health; I31 General Welfare; Well-Being;
D O I
暂无
中图分类号
学科分类号
摘要
Phenylketonuria (PKU) is a metabolic disorder leading to a deficiency in the metabolism of phenylalanine (Phe). Elevated Phe levels in the blood, tissue and brain may lead to emotional, cognitive, and physical symptoms in adults. To control blood Phe levels, most individuals with PKU need to follow a strict, life-long Phe-restricted diet. The main objective of this study was to estimate the impact of PKU-related disease symptoms and dietary restrictions on health-related quality of life (HRQoL). This study was designed as a web-based survey using the methods of Time Trade-Off (TTO) and Discrete Choice Experiment with duration (DCETTO) in a survey of the Swedish general population and population with PKU. Data were collected using questionnaires for TTO diet (n = 509), TTO symptoms (n = 507), and DCETTO (n = 1117). The disutility of diet restrictions ranged from 0.050 for a partially restricted diet without medical food to 0.193 for a fully restricted diet with medical food in the TTO (DCE: 0.043–0.108). The disutility of experiencing symptoms (emotional, cognitive and physical) ranged from 0.148 for mild symptoms to 0.593 for severe symptoms in the TTO (DCE: 0.122–1.522). The study shows that both diet and symptoms have a significant negative impact on HRQoL in PKU and that utility estimates are largely consistent across methods and samples.
引用
收藏
页码:993 / 1005
页数:12
相关论文
共 50 条
  • [31] Exploring the Trade-Off Between Economic and Health Outcomes During a Pandemic: A Discrete Choice Experiment of Lockdown Policies in Australia
    Manipis, Kathleen
    Street, Deborah
    Cronin, Paula
    Viney, Rosalie
    Goodall, Stephen
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (03): : 359 - 371
  • [32] Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods
    Bourke, Siobhan M.
    Plumpton, Catrin O.
    Hughes, Dyfrig A.
    VALUE IN HEALTH, 2018, 21 (05) : 538 - 546
  • [33] Exploring the Trade-Off Between Economic and Health Outcomes During a Pandemic: A Discrete Choice Experiment of Lockdown Policies in Australia
    Kathleen Manipis
    Deborah Street
    Paula Cronin
    Rosalie Viney
    Stephen Goodall
    The Patient - Patient-Centered Outcomes Research, 2021, 14 : 359 - 371
  • [34] The influence of subjective expectations about length and quality of life on time trade-off answers
    van Nooten, F
    Brouwer, W
    HEALTH ECONOMICS, 2004, 13 (08) : 819 - 823
  • [35] Better Quality of Life Over More Quantity of Life: How We View Time Trade-Off
    O'Connor, Christopher M.
    JACC-HEART FAILURE, 2019, 7 (06) : 531 - 532
  • [36] Estimation of Health Utility and Quality Adjusted Life Years in Bilateral Hand Transplantation A Time Trade-off Study
    Harijee, Ankita
    Thankappan, Krishnakumar
    Sharma, Mohit
    NageswaraRao, Nagesh Noothanapati
    Patel, Tejal
    Bhaskaran, Renjitha
    Raj, Manu
    Sundaram, Karimassery Ramaiyer
    Iyer, Subramania
    ANNALS OF PLASTIC SURGERY, 2021, 86 (03) : 345 - 350
  • [37] Time Trade-Off as a Measure of Health-Related Quality of Life: Long Bone Nonunions Have a Devastating Impact
    Schottel, Patrick C.
    O'Connor, Daniel P.
    Brinker, Mark R.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2015, 97A (17): : 1406 - 1410
  • [38] The episodic random utility model unifies time trade-off and discrete choice approaches in health state valuation
    Craig B.M.
    Busschbach J.J.V.
    Population Health Metrics, 7 (1)
  • [39] Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension
    Wu, Jing
    Xie, Shitong
    He, Xiaoning
    Chen, Gang
    Bai, Gengliang
    Feng, Da
    Hu, Ming
    Jiang, Jie
    Wang, Xiaohui
    Wu, Hongyan
    Wu, Qunhong
    Brazier, John E.
    PHARMACOECONOMICS, 2021, 39 (05) : 521 - 535
  • [40] Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension
    Jing Wu
    Shitong Xie
    Xiaoning He
    Gang Chen
    Gengliang Bai
    Da Feng
    Ming Hu
    Jie Jiang
    Xiaohui Wang
    Hongyan Wu
    Qunhong Wu
    John E. Brazier
    PharmacoEconomics, 2021, 39 : 521 - 535